Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer Patients
Conditions: Breast Cancer; DCIS Interventions: Drug: (Z)-Endoxifen supplementation according to genotype; Drug: (Z)-Endoxifen supplementation according to plasma levels Sponsor: Robert Bosch Gesellschaft für Medizinische Forschung mbH Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | DCIS (Ductal Carcinoma in Situ) | Ductal Carcinoma | Research | Tamoxifen